, Tracking Stock Market Picks
Enter Symbol:
Medtronic, Inc. (MDT) [hlAlert]

Average MDT
up 22.96 %

Medtronic, Inc. (MDT) downgraded to Average with price target $40 by Caris & Company

Posted on: Wednesday,  Aug 26, 2009  9:25 AM ET by Caris & Company

Caris & Company rated Average Medtronic, Inc. (NYSE: MDT) on 08/26/2009. Previously Caris & Company rated Above Average Medtronic, Inc. (NYSE: MDT)
on 11/20/2008., when the stock price was $30.78. Since then, Medtronic, Inc. has gained 22.97% as of 08/26/2009's recent price of $37.85.
If you would have followed the previous Caris & Company's recommendation on MDT, you would have gained 22.96% of your investment in 279 days.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

Caris & Company, an investment bank created by a diverse group of leading Wall Street professionals. We are founded on the basic principle that Wall Street requires a different type of organization: One that offers objective, conflict-free research, acute focus on customer service, broad institutional coverage, and an unwavering commitment to increasing the value of our clients' portfolios. Quite simply, our goal is to generate solid investment ideas for our clients. We offer a unique, differentiated, conflict-free research perspective on large, mid, and small capitalization companies in four growth oriented verticals: Health Care, Technology, Energy, and Consumer.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/26/2009 9:25 AM Hold
37.85 40.00
as of 12/31/2009
1 Week   
1 Month   
3 Months   
1 YTD up  20.46 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2008 1:25 PM Buy
30.78 34.00
9/5/2008 8:25 AM Hold
53.43 60.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy